Frontiers in Pharmacology (Apr 2023)
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury
- Jiajia Li,
- Jiajia Li,
- Jiajia Li,
- Yupeng Jiang,
- Yupeng Jiang,
- Yupeng Jiang,
- Yupeng Jiang,
- Qin Dai,
- Yue Yu,
- Xin Lv,
- Yan Zhang,
- Xiaohua Liao,
- Liyun Ao,
- Gaoyun Hu,
- Jie Meng,
- Jie Meng,
- Zhangzhe Peng,
- Zhangzhe Peng,
- Zhangzhe Peng,
- Lijian Tao,
- Lijian Tao,
- Lijian Tao,
- Yanyun Xie,
- Yanyun Xie,
- Yanyun Xie
Affiliations
- Jiajia Li
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Jiajia Li
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Jiajia Li
- National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China
- Yupeng Jiang
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Yupeng Jiang
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Yupeng Jiang
- National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China
- Yupeng Jiang
- Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China
- Qin Dai
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Yue Yu
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Xin Lv
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Yan Zhang
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Xiaohua Liao
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Liyun Ao
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Gaoyun Hu
- Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
- Jie Meng
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Jie Meng
- Department of Pulmonary and Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, China
- Zhangzhe Peng
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Zhangzhe Peng
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Zhangzhe Peng
- National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China
- Lijian Tao
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Lijian Tao
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Lijian Tao
- National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China
- Yanyun Xie
- Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China
- Yanyun Xie
- Hunan Key Lab of Organ Fibrosis, Changsha, China
- Yanyun Xie
- National International Collaborative Research Center for Medical Metabolomics, Xiangya Hospital, Central South University, Changsha, China
- DOI
- https://doi.org/10.3389/fphar.2023.1188615
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
